Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YY1201 in Knee Osteoarthritis
NCT02554552Phase 2Withdrawn
- Sponsor
- Yooyoung Pharmaceutical
- Start
- Sep 2015
- Primary completion
- Oct 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of YYD302 in osteoarthritis (OA), sponsored by Yooyoung Pharmaceutical. Planned start Sep 2015; status: withdrawn.
02
Drugs
YYD302
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02554552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554552.